Medigene AG announced that the Executive Management Board expects revenue in 2023 to be between EUR 5 million and EUR 7 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.448 EUR | +0.56% | -5.50% | -4.26% |
05-08 | Medigene Boosts Share Capital Via Rights Offering, Private Placement | MT |
05-02 | Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 - Targeted T Cell Receptor | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.26% | 38.11M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.47% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene AG Provides Revenue Guidance for 2023